NCT00833547View on ClinicalTrials.gov

Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Schizophrenia
Interventions
DRUG

eszopiclone

3 mg of eszopiclone at bedtime on two consecutive nights

DRUG

placebo

Placebo capsules looking identical to eszopiclone at bedtime on two consecutive nights

Trial Locations (1)

02114

Mass General Hospital, Boston

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

collaborator

Beth Israel Deaconess Medical Center

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00833547 - Effects of Eszopiclone on Sleep-dependent Learning in Schizophrenia | Biotech Hunter | Biotech Hunter